Outcomes following hematopoietic cell transplantation for WiskottAldrich syndrome

Bone Marrow Transplantation

Volumn 47, Issue 11, 2012, Pages 1428-1435

  Shin, C R ^a   Kim, M O ^a   Li, D ^a   Bleesing, J J ^a   Harris, R ^a   Mehta, P ^a   Jodele, S ^a   Jordan, M B ^a   Marsh, R A ^a   Davies, S M ^a   Filipovich, A H ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

hematopoietic cell transplantation; long term outcomes; Wiskott Aldrich syndrome(s)

Indexed keywords

CD34 ANTIGEN; WISKOTT ALDRICH SYNDROME PROTEIN;

ACUTE GRAFT VERSUS HOST DISEASE; ADENOVIRUS INFECTION; ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CYTOPENIA; DONOR SELECTION; GENE; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; IMMUNOPATHOLOGY; INDEL MUTATION; INFANT; MALE; MISSENSE MUTATION; MULTIPLE ORGAN FAILURE; MUTATIONAL ANALYSIS; NONSENSE MUTATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POST TRANSPLANT AUTOIMMUNE CYTOPENIA; POST TRANSPLANT MIXED CHIMERISM; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY FAILURE; SCHOOL CHILD; SPLICING DEFECT; SURVIVAL TIME; WASP GENE; WISKOTT ALDRICH SYNDROME;

ADOLESCENT; ADULT; COHORT STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; WISKOTT-ALDRICH SYNDROME; YOUNG ADULT;

EID: 84869081476     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2012.31     Document Type: Article

References (16)

1. Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. A multi-institutional survey of the Wiskott Aldrich Syndrome. J Pediatr 1994; 125: 876-885. (Pubitemid 24379120)
2. Ochs HD, Thrasher AJ. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol 2006; 117: 725-738. (Pubitemid 44313817)
3. Imai K, Morio T, Zhu Y, Jin Y, Itoh S, Kajiwara M et al. Clinical course of patients with WASP gene mutations. Blood 2004; 103: 456-464. (Pubitemid 38140073)
4. Parkman R, Rappeport J, Geha R, Belli J, Cassady R, Levey R et al. Complete correction of the Wiskott-Aldrich Syndrome by allogeneic bone-marrow transplantation. N Engl J Med 1978; 298: 921-927. (Pubitemid 8325836)
5. Bach FH, Albertini RJ, Joo P, Anderson JL, Bortin MM. Bone marrow transplantation in a patient with the Wiskott Aldrich Syndrome. Lancet 1968; 292: 1362-1366.
6. Ozsahin H, Le Deist F, Benkerrou M, Cavazzana-Calvo M, Gomez L, Griscelli C et al. Bone marrow transplantation in 26 patients with Wiskott-Aldrich Syndrome from a single center. J Pediatr 1996; 129: 238-244. (Pubitemid 27483795)
7. Filipovich AH, Stone JV, Tomany SC, Ireland M, Kollman C, Pelz CJ et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich Syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood 2001; 97: 1598-1603. (Pubitemid 32217223)
8. Pai S-Y, DeMartiis D, Forino C, Cavagnini S, Lanfranchi A, Giliani S et al. Stem cell transplantation for the Wiskott-Aldrich Syndrome: a single center experience confirms efficacy of matched unrelated donor transplantation. Bone Marrow Transplant 2006; 38: 671-679. (Pubitemid 44669682)
9. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295-304.
10. Filipovich AH, Weisdorf D, Palvetic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945-956. (Pubitemid 41754712)
11. Kaplan EL, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457-481.
12. Peto P, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Part II. Br J Cancer 1977; 35: 1-39. (Pubitemid 8018922)
13. Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 187-200.
14. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141-1154.
15. Moratto D, Giliani S, Bonfim C, Mazzolari E, Fischer A, Ochs HD et al. Long term outcome and lineage-specific chimerism in 194 Wiskott-Aldrich syndrome patients treated by hematopoietic cell transplantation between 1980-2009: an international collaborative study. Blood 2011; 118: 1675-1684.
16. Ozsahin H, Cavazzana-Calvo M, Notarangelo LD, Schulz A, Thrasher AJ, Mazzolari E et al. Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation. Blood 2008; 111: 439-445.